Skip to content
HowShorted

MADRIGAL PHARMACEUTICALS, INC. short interest in 2026

In 2026, MADRIGAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 16.99% of shares outstanding on 15 Jan 2026 to 9.76% on 15 Sep 2026, a change of -7.23 percentage points. The year's high was 17.54% on 30 Jan 2026 and its low 8.51% on 31 Jul 2026, averaging 14.47% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.47 days on 30 Apr 2026. Full history: MADRIGAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MADRIGAL PHARMACEUTICALS, INC. in 2026

2026 in figures

Start of year
16.99% (15 Jan 2026)
End of year
9.76% (15 Sep 2026)
Change
-7.23 pp
High
17.54% (30 Jan 2026)
Low
8.51% (31 Jul 2026)
Average
14.47%
Highest days to cover
16.47 (30 Apr 2026)
SEC filings marked
6

Every report in 2026

MADRIGAL PHARMACEUTICALS, INC. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202616.99%9.77
30 Jan 202617.54%12.69
13 Feb 202615.78%11.08
27 Feb 202616.31%8.1610-K filed, results (8-K)
13 Mar 202617.13%13.93
31 Mar 202617.04%9.12
15 Apr 202617.49%12.69
30 Apr 202616.80%16.47
15 May 202616.90%12.3310-Q filed, results (8-K)
29 May 202616.58%14.08
15 Jun 202616.40%14.32
30 Jun 202615.30%6.20
15 Jul 20268.95%6.94
31 Jul 20268.51%4.8410-Q filed, results (8-K)
14 Aug 20268.77%6.05
31 Aug 20269.70%9.46
15 Sep 20269.76%11.42

See also: MADRIGAL PHARMACEUTICALS, INC.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.